Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,2,4-triazole, Potassium Salt
1. 1h-1,2,4-triazole
2. 288-88-0
3. 4h-1,2,4-triazole
4. Pyrrodiazole
5. S-triazole
6. 1,2,4-1h-triazole
7. 63598-71-0
8. Mfcd00005228
9. Nsc 83128
10. Dtxsid6027131
11. Peptone, Bacteriological
12. 1h-[1,2,4]triazole
13. 10ms0y1rdi
14. Chebi:46077
15. Nsc-83128
16. (1,2,4)-triazole
17. [1,2,4]-triazole
18. 736917-78-5
19. 1,2,4 Triazole
20. 1h-1,2,4-triazol
21. 1,2,4-triazol
22. 4h-1,2,4-triazole (van)
23. Einecs 206-022-9
24. Unii-10ms0y1rdi
25. Ai3-51031
26. Hsdb 7860
27. 1,4-triazole
28. 1,2,4triazole
29. 1,3,4-triazole
30. 1h-1,4-triazole
31. 4h-1,4-triazole
32. [1,2,4]triazole
33. 1,2, 4-triazole
34. 1,2,4,-triazole
35. [1,2,4]triazol
36. [1.2.4]-triazole
37. 1, 2, 4 Triazole
38. [1,2,4]-triazol
39. 1,2,4-1h Triazole
40. Dsstox_cid_7131
41. Ec 206-022-9
42. 4h-[1,2,4]triazole
43. Dsstox_rid_78318
44. Dsstox_gsid_27131
45. 1h-[1,2,4]-triazole
46. Chembl15571
47. 1,2,4-triazole, 98%
48. Niosh/xz3807000
49. Chebi:35550
50. Efinaconazole Metabolite H1
51. Amy40414
52. Bcp20885
53. Cs-d1150
54. Nsc83128
55. Triazole, 1h,1,2,4-
56. Zinc5943507
57. Tox21_300113
58. Cga-71019
59. Mfcd01941334
60. Stk366100
61. 1,2,4-triazole, Analytical Standard
62. 1h-1,2,4-triazole [mi]
63. Akos000120326
64. Akos000269054
65. 1h-1,2,4-triazole [hsdb]
66. Db03594
67. Ps-9377
68. Ncgc00247903-01
69. Ncgc00254087-01
70. Bp-12667
71. Cas-288-88-0
72. Sy001414
73. Db-002017
74. Bb 0267986
75. Cs-0368547
76. Ft-0607865
77. T0340
78. Xz38070000
79. 88t880
80. E76126
81. T-6200
82. 1,2,4-triazole, Vetec(tm) Reagent Grade, 98%
83. A819652
84. Q161300
85. F1918-0085
86. Z1245636363
| Molecular Weight | 69.07 g/mol |
|---|---|
| Molecular Formula | C2H3N3 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 69.032697108 g/mol |
| Monoisotopic Mass | 69.032697108 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 5 |
| Formal Charge | 0 |
| Complexity | 28.1 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
After a single oral administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx 100% of the (14)C activity was absorbed from the digestive tract.
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
8 hr after a single iv administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx 50% of the applied radioactivity was detectable in the body of the animals (gastrointestinal tract not considered). 3 days after the application approx 1.5% of the applied activity could be found, and after 6 days the (14)C-activity was no longer measurable (detection limit 0.3%).
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
Following a single oral or iv administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx. 0.1% of the (14)C-activity was exhaled within 30 hr.
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
1H-1,2,4-Triazole (14)C-labeled was administered to male rats orally (dose: 1 mg/kg bw) or iv (doses: 0.1, 1, 10, 100 mg/kg bw). Within 48 hr after the single application 92-94% of the (14)C-activity was excreted with the urine and 3-5% with the feces, regardless whether the substance was applied orally or iv.
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
For more Absorption, Distribution and Excretion (Complete) data for 1H-1,2,4-Triazole (6 total), please visit the HSDB record page.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
